Between the Clinic and the Laboratory
Alexander Grinberg, MD, is a physician and biotechnology advisor whose work spans integrative and longevity medicine, clinical immunology, peptide pharmacology, and regenerative medicine. His career combines patient care with the evaluation and development of new therapies.
He earned his medical degree at Tashkent State Medical Institute in 1988 and undertook postgraduate research and training in clinical immunology at the Moscow Research Institute of Immunology from 1988 to 1992, including three years in a doctoral program. His early laboratory experience with short-chain peptides and bioregulators informs his approach to the field’s historical evidence base.
In San Francisco, he served as an attending physician at St. Luke’s Hospital from 1998 to 2004 and established a private integrative medicine practice in 2000. He founded Infinity Epigenetics in 2023, focusing on the interpretation of epigenetic and genomic information for individualized health planning.
Alongside clinical practice, his work has included biotechnology leadership, scientific due diligence, clinical study design, and advisory roles in immunotherapy, biospecimen research, and peptide, cell and gene therapies.